Premium Information is available for this item - Upgrade for $1 a day
6530-01-657-3401
Apoc Blood Gas
6530016573401 016573401 05P71-01
January 2023
3
Marketplace 6530-01-657-3401
Request a Quotation from participating marketplace vendors
Related Documents 6530-01-657-3401 5+ Documents (More...)
(Active) Primary Buy RNCC 3 RNVC 2 DAC 4 05P71-01 33110 - Abbott Laboratories Inc.
1462419 89875 - Defense Logistics Agency (Active) Incomplete Secondary Reference RNCC 5 RNVC 1 DAC 4 05P71-01
Restrictions 6530-01-657-3401
6530-01-657-3401 is a Apoc Blood Gas that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 6530-01-657-3401
- United Kingdom (ZK01)
- Effective Date:
- 1 Aug 2016
Approved Sources 6530-01-657-3401
- Part Number
- Manufacturer
- Status
- 05P71-01
- Manufacturer
- 6AWN5 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- 05P71-01
- U7F35 - Abbott Laboratories Ltd Diagnostics (Active)
- Secondary Buy
- Secondary Buy
- 05P71-01
- U09Q8 - Safeguard Medical Technologies Ltd (Active)
- Secondary Buy
- Secondary Buy
- 05P71-01
- U16D1 - Lumiradx Ltd (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6530-01-657-3401
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Part Name Assigned By Controlling Agency [CXCY]
- Apoc
- Special Features [FEAT]
- Liquid, Blue, Odourless; Control Level 1
NATO Stock Numbers Related to 6530-01-657-3401
Freight Information 6530-01-657-3401
6530-01-657-3401 has freight characteristics.. 6530-01-657-3401 has a variance between NMFC and UFC when transported by rail and the description should be consulted.